circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer (vol 51, pg 2224, 2018)

被引：0

|

作者：

An, Yong

Cai, Huihua

Zhang, Yue

Liu, Shengyong

Duan, Yunfei

Sun, Donglin

Chen, Xuemin

He, Xiaozhou

机构：

来源：

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2021年 / 55卷 / 03期

关键词：

D O I：

10.33594/000000385

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

收藏

页码：380 / 381

页数：2

相关论文

共 50 条

[41] RETRACTION: MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2 (Retraction of Vol 23, Pg 2847, 2019)
Shi, X. -Y.
Wang, H.
Wang, W.
Gu, Y-H.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 10914 - 10914
[42] Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis (vol 78, pg 4586, 2018)
Wang, Xiaofeng
Luo, Guangtao
Zhang, Kundong
Cao, Jun
Huang, Chen
Jiang, Tao
Liu, Bingya
Su, Liping
Qiu, Zhengjun
CANCER RESEARCH, 2020, 80 (04) : 922 - 922
[43] miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (vol 25, pg 68, 2018)
Zhou, Xinliang
Men, Xinyi
Zhao, Riyang
Han, Jing
Fan, Zhisong
Wang, Yudong
Lv, Yalei
Zuo, Jing
Zhao, Lianmei
Sang, Meixiang
Liu, Xian-De
Shan, Baoen
CANCER GENE THERAPY, 2020, 27 (12) : 976 - 978
[44] Ligating similarities between the novel five-electron-donor η4-P3C2Bu2t(R)H ring system, (R=CH(SiMe3)2) and the η5-cyclopentadienyl ring.: Syntheses, crystal and molecular structures of [Co2(Co)5(μ-P3C2Bu2tCH(SiMe3)2] and [Co(Co)2(η4-P3C2Bu2tH(CH(SiMe3)2] (vol 601, pg 335, 2000)
Hitchcock, PB
Nixon, JF
Sakarya, N
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2002, 662 (1-2) : 193 - 193
[45] RETRACTION: MiR-185-5p measurement assists in reflecting Th1/Th2 cell imbalance, inflammatory cytokine production, and exacerbation risk for childhood asthma (Retraction of Vol 51, Pg 91, 2023)
Li, Chunmei
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (03) : 194 - 194
[46] RETRACTION: MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 (Retraction of Vol 44, Pg 1785, 2017)
Lv, Zhi-Dong
Yang, Dong-Xia
Liu, Xiang-Ping
Jin, Li-Ying
Wang, Xin-Gang
Yang, Zhao-Chuan
Liu, Dong
Zhao, Jiao-Jiao
Kong, Bin
Li, Fu-Nian
Wang, Hai-Bo
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2023, 57 (03) : 199 - 199
[47] RETRACTION: LncRNA OTUD6B-AS1 inhibits many cellular processes in colorectal cancer by sponging miR-21-5p and regulating PNRC2 (vol 40, pg 1463, 2021) (Retraction of Vol 40, Pg 1463, 2021)
Cai, Y.
Li, Y.
Shi, C.
Zhang, Z.
Xu, J.
Sun, B.
HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
[48] lncRNA HOXD-AS2 regulates miR-3681-5p/DCP1A axis to promote the progression of non-small cell lung cancer (vol 15, pg 1289, 2023)
Zhang, Y.
Ma, H.
JOURNAL OF THORACIC DISEASE, 2024, 16 (01) : 821 - 824
[49] circFCHO2 promotes gastric cancer progression by activating the JAK1/STAT3 pathway via sponging miR-194-5p (Vol 21, pg 2145, 2022)
Zhang, Zhe
Sun, Chengying
Zheng, Yan
Gong, Yanying
CELL CYCLE, 2024, 23 (03) : 338 - 338
[50] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
Wang, Y.
Wang, X.
Han, L.
Hu, D.
CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457

← 1 2 3 4 5 →